Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

Clinical trial NCT01420926 · COMPLETED

Trial details

NCT number: NCT01420926
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Therapy-Related Acute Myeloid Leukemia

Start date: 2011-11-16
Primary completion: 2016-06-05
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.